Valuation: Kamada Ltd.

Market Cap 1.25B 0 409M 359M 334M 307M 576M 39.4B 585M 3.97B 1.55B 19.37B 1.54B 1.5B 66.97B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 1.25B 0 409M 359M 334M 307M 576M 39.4B 585M 3.97B 1.55B 19.37B 1.54B 1.5B 66.97B EV / Sales 2026 *
2.08x
EV / Sales 2027 * 1.9x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
1 day-0.46%
1 week-1.87%
Current month-1.65%
1 month-1.15%
3 months-12.32%
6 months-20.69%
Current year-4.87%
1 week 2,140
Extreme 2140
2,230
1 month 2,076
Extreme 2076
2,297
Current year 2,076
Extreme 2076
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 64 24/12/2019
Chairman 77 07/03/2013
Director/Board Member 75 13/12/1990
Date Insider Type Main position Quantity % Market Cap.
4/7/26 A Free

Responsable ventes & marketing

150,000 0.2600%
4/7/26 A Free

Head of Human Resources

200,000 0.3467%
4/7/26 A Free

General Counsel

198,970 0.3449%
Change 5-day change 1-year change 3-year change Capi.($)
-0.46%-1.87%-17.97%+16.15% 409M
+0.63%-3.06%+16.50%-10.25% 66.74B
-0.16%+3.19%+37.32%+203.73% 53.32B
+10.08%+51.80%+51.80%+51.80% 48.12B
+1.90%-5.07%-56.99%-56.52% 38.25B
+0.78%-1.84%+53.73%-23.77% 29.85B
+0.84%+0.36%+67.62%+87.37% 23.51B
-5.17%-12.54%+58.33%-55.18% 21.45B
+1.31%+3.24%+81.47%+159.24% 16.47B
-0.07%-1.08%+62.53%+123.85% 16.38B
Average +0.97%-0.52%+35.43%+49.64% 31.45B
Weighted average by Cap. +1.73%+0.01%+32.46%+48.73%

Financials

2026 *2027 *
Net sales 600M 0 197M 173M 161M 148M 278M 18.98B 282M 1.91B 747M 9.33B 740M 724M 32.26B 655M 0 215M 189M 176M 161M 303M 20.7B 307M 2.08B 814M 10.17B 807M 789M 35.18B
Net income 73.89M 0 24.26M 21.31M 19.82M 18.18M 34.17M 2.34B 34.69M 235M 91.93M 1.15B 91.08M 89.11M 3.97B 105M 0 34.62M 30.4M 28.27M 25.94M 48.75M 3.33B 49.5M 336M 131M 1.64B 130M 127M 5.67B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
27/07/26 ILA 2,150.00 -0.46% 5,332
24/07/26 ILA 2,160.00 -0.60% 30,768
22/07/26 ILA 2,173.00 -1.27% 78,689
21/07/26 ILA 2,201.00 +0.46% 43,808
20/07/26 ILA 2,191.00 +2.77% 422,843
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock